Glutarate

Glutarate

SCHEMBL219714

CCN(CC)CC.O=C(O)CCCC(=O)O

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 2/20 0.61
AKR1B1 P15121 1/20 0.55
LMNA P02545 2/20 0.53
GPR84 Q9NQS5 7/20 0.52
PPARG P37231 7/20 0.52
PPARD Q03181 7/20 0.52
PPARA Q07869 7/20 0.52
TSHR P16473 6/20 0.52
HDAC11 Q96DB2 5/20 0.52
PTPN1 P18031 3/20 0.52
ALDH1A1 P00352 2/20 0.52
TLR2 O60603 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
FABP4 P15090 2/20 0.52
SLC22A8 Q8TCC7 1/20 0.52
MEN1 O00255 1/20 0.52
ESR1 P03372 1/20 0.52
ALOX15 P16050 1/20 0.52
PDE4A P27815 1/20 0.52
KMT2A Q03164 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutarate SCHEMBL5875071 1.00 SLC22A6 (0.61) SLC22A6AKR1B1LMNAGPR84PPARG
Adipic Acid SCHEMBL5875010 0.94 AKR1B1 (0.62) SLC22A6AKR1B1LMNAGPR84PPARG
Adipic Acid SCHEMBL5875018 0.94 AKR1B1 (0.62) SLC22A6AKR1B1LMNAGPR84PPARG
Azelaic Acid SCHEMBL17140336 0.92 GPR84 (0.64) SLC22A6AKR1B1LMNAGPR84PPARG
SCHEMBL10891072 0.92 GPR84 (0.64) SLC22A6AKR1B1LMNAGPR84PPARG
SCHEMBL10891070 0.92 GPR84 (0.64) SLC22A6AKR1B1LMNAGPR84PPARG
Sebacic Acid SCHEMBL5874634 0.92 GPR84 (0.64) SLC22A6AKR1B1LMNAGPR84PPARG
Sebacic Acid SCHEMBL5874637 0.92 GPR84 (0.64) SLC22A6AKR1B1LMNAGPR84PPARG
Valeric Acid SCHEMBL3414377 0.90 AKR1B1 (0.64) SLC22A6AKR1B1GPR84PPARGPPARD
Succinic Acid SCHEMBL5874898 0.88 LMNA (0.56) SLC22A6AKR1B1LMNAGPR84PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088548-B2 Bottom antireflective coating compositions AZ ELECTRONIC MATERIALS USA CORP. (US) 2012-01-03 US disclosed
EP-2212273-A2 BOTTOM ANTIREFLECTIVE COATING COMPOSITIONS AZ Electronic Materials USA Corp. (US) 2010-08-04 EP disclosed
WO-2009053832-A2 BOTTOM ANTIREFLECTIVE COATING COMPOSITIONS AZ ELECTRONIC MATERIALS USA CORP. (DE) 2009-04-30 WO disclosed
US-20090104559-A1 Bottom Antireflective Coating Compositions MERCK PATENT GMBH (DE) 2009-04-23 US disclosed
US-7128976-B2 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2006-10-31 US disclosed
US-20030091838-A1 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2003-05-15 US disclosed
US-5567597-A DIAGNOSING THE DISEASE BY DETECTING, MEASURING THE LIPASE, PHOSPHOLIPASE, ESTERASE, PROTEASE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1996-10-22 US disclosed
US-5427919-A Therapy, analysis substrates THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1995-06-27 US disclosed
US-5352673-A Administering to inactivate or inhibit phospholipase A REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE A CORP. OF CALIFORNIA 1994-10-04 US disclosed
US-5308766-A Hydrolytic enzyme inhibitors/inactivators and methods for using same THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1994-05-03 US disclosed
WO-1992022289-A1 NOVEL PHOSPHOLIPASE A2 INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1992-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090104559-A1 Bottom Antireflective Coating Compositions SDC2, S100A9, MYH9 SLC22A6 1567/4885AKR1B1 3022/4885LMNA 686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.